Comprehensive Medical Case Reviews and Clinical Management Notes

Clinical Case Review: Pulmonology and Renal Management

  • Pulmonary Diagnostic Evaluation:

    • Differentiation between Chronic Obstructive Pulmonary Disease (COPD) versus Interstitial Lung Disease (ILD) and other spastic pulmonary disorders.
    • Assessment of patient presentation regarding potential interstitial lung involvement rather than classic COPD presentation.
  • Renal Window & Dosing Guidelines:

    • Medication dosing consideration: 75 mg75\,\text{mg} formulation administered as 75 mg75\,\text{mg} twice daily (75 mg BID75\,\text{mg}\text{ BID}).
    • Paracentesis scheduled for the day to relieve intra-abdominal pressure and resolve Acute Kidney Injury (AKI).
    • Dosing adjustments during renal function decline: Balloon bill taken when renal function worsened. Regimen reduced by half (50%50\% reduction) during acute renal decline.
    • Plan to escalate back to a full single-dose regimen once renal function recovers and stabilizes.
    • Team scheduling note: Attending/resident team unavailable the following day due to a designated wellness day.
  • Metastatic Breast Cancer & Pain Management:

    • Female patient with metastatic breast cancer and a history of chronic spinal compression fractures.
    • Currently maintained on an intensive outpatient chronic pain regimen at home.
    • Diagnostic workup includes blood cultures, sputum cultures, and additional infectious studies.
    • Goals of care discussion: Patient expresses uncertainty regarding further aggressive interventions, specifically regarding palliative brain radiation therapy; decision pending patient consideration.
  • Septic Presentation & Post-Stroke Care (Mr. Fogler):

    • Presentation: Sepsis-like clinical picture in a patient with a history of prior cerebrovascular accident (stroke).
    • Hemodynamics: Baseline hypertension noted; outpatient amlodipine dose was increased.
    • Current Medication Regimen: Amlodipine, Toradol (ketorolac), hydralazine, and IV cefepime (scheduled to complete therapy course tomorrow).
    • Clinical Status: Patient reports feeling well, highly motivated for transfer to inpatient physical/occupational rehabilitation.
  • Hematologic & Infectious Workup:

    • Complete Blood Count (CBC) monitoring: Hemoglobin drop noted from 11.5 g/dL11.5\,\text{g/dL} down to 9.6 g/dL9.6\,\text{g/dL}.
    • Clinical Assessment: No overt signs of active bleeding, short of breath, or localized pain.
    • Repeat CBC ordered for 2:00 PM2\text{:00 PM} today to recheck hemoglobin trajectory.
    • Antimicrobial Coverage: Empiric Vancomycin and Zosyn (piperacillin/tazobactam) for lower extremity cellulitis.
    • Imaging: Magnetic Resonance Imaging (MRI) scheduled today; discontinuation of Vancomycin pending Infectious Disease (ID) clearance.
    • Antiviral Management: Primary care provider (PCP) prescribes Acyclovir for recurrent herpes zoster (shingles); confirmed as an as-needed (PRN) home medication and discontinued from routine inpatient administration.
    • Prophylaxis: Patient routinely refusing Lovenox (enoxaparin) administration. Patient currently utilizing supplemental nasal cannula oxygen.

Cardiology and Outpatient Care Coordination

  • Diagnostic & Lab Parameters:

    • Serum Creatinine: Very low at 0.2 mg/dL0.2\,\text{mg/dL} (reflecting baseline frail body habitus).
    • Leukocytes: Known baseline leukopenia ranging between 1.0×103/μL1.0 \times 10^3/\mu\text{L} and 2.0×103/μL2.0 \times 10^3/\mu\text{L}.
    • Hemoglobin: Mild baseline anemia at 11.6 g/dL11.6\,\text{g/dL} (11.4 g/dL11.4\,\text{g/dL} on the previous day).
    • Hepatic Function: Borderline Alanine Aminotransferase (ALT) at 37 U/L37\,\text{U/L} (43 U/L43\,\text{U/L} yesterday); Total Bilirubin (TB) at 1.3 mg/dL1.3\,\text{mg/dL} (1.2 mg/dL1.2\,\text{mg/dL} yesterday).
  • Cardiology Treatment Adjustments:

    • Plan: Discontinue Lopressor (metoprolol) and initiate Farxiga (dapagliflozin).
    • Cardiology recommendations: Transthoracic Echocardiogram (TTE) with saline bubble study and a Right Heart Catheterization (RHC).
    • Procedure Refusal & Misconceptions: Family/daughter denied RHC due to fear of general anesthesia based on a previous traumatic hard extubation experience. Clarification provided that general anesthesia is not utilized for catheterization procedures.
  • Communication & Cultural Considerations:

    • Language barrier: Patient speaks a specific dialect of Burmese distinct from the hospital interpreter's Burmese dialect.
    • Communication relay chain required: Hospital Translator -> Daughter -> Patient.
    • Decision-making capacity: Patient exhibits significant risk aversion regarding invasive medical procedures.
    • Outpatient Disposition: If all invasive inpatient procedures are refused, patient is cleared for home discharge with outpatient cardiology follow-up.
  • Complex Renal & Hematologic Presentation:

    • Pain status: Subjective pain reported as improved following pain medication administration.
    • Laboratory Values: Serum Potassium 5.5 mEq/L5.5\,\text{mEq/L}, Serum Sodium 134 mEq/L134\,\text{mEq/L}. Hemodialysis scheduled for today.
    • Hematology: Profound leukocytosis noted secondary to high-dose steroid administration (13 hours13\,\text{hours} post-dose), deemed non-infectious in etiology. Hemoglobin stable at 7.3 g/dL7.3\,\text{g/dL} (7.2 g/dL7.2\,\text{g/dL} yesterday); no transfusions required.
    • Microbiology: Urine culture positive for >100,000 CFU/mL> 100,000\,\text{CFU/mL} Gram-negative rods; targeted antimicrobial therapy active.
    • Multidisciplinary Team: Urology follow-up for formal CP leave/urinary management, Interventional Radiology (IR), and Palliative Care consultation (on list to be seen today).

Inpatient Pain Management, Infection, and Metabolic Care

  • Intravenous Acetaminophen Policy & Restrictions:

    • IV Tylenol (acetaminophen) restricted per Pharmacy and Therapeutics (P&T) hospital guidelines.
    • Scheduling criteria: Patient must have strict Nil Per Os (NPO) orders or be in an immediate post-procedural setting (maximum 11 post-procedure dose allowed).
    • Cannot schedule IV Tylenol 3×daily3 \times \text{daily} without strict NPO documentation.
    • Fluid Intake Refusal: Patient refusing oral medications/liquids (ingested only 300 mL300\,\text{mL} of 900 mL900\,\text{mL} oral fluid restriction/order).
    • Co-administered IV Fentanyl active on patient's MAR for acute pain management.
  • Urinary & Metabolic Control in Cellulitis:

    • Management of bilateral lower extremity cellulitis and osteomyelitis.
    • Failed Trial of Void: Foley catheter re-inserted yesterday following a failed trial of void; straight catheterization yielded 1.4 L1.4\,\text{L} (1,400 mL1,400\,\text{mL}) of retained urine with associated suprapubic tenderness.
    • Patient exhibited mild agitation with catheter presence but was counseled to retain it.
    • Glycemic Control: Insulin Glargine (Lantus) initiated yesterday afternoon for blood glucose levels >200 mg/dL> 200\,\text{mg/dL}; current blood glucose successfully maintained <200 mg/dL< 200\,\text{mg/dL}.
    • Antimicrobial Regimen: IV Unasyn (ampicillin/sulbactam) and IV Vancomycin. Patient afebrile overnight; blood and urine cultures show no growth to date.
  • Physical & Laboratory Trajectory:

    • Physical Status: Mild disorientation upon awakening. Abdominal pain improving; persistent mild cramping without major suprapubic distension. Lower extremity foot wounds remain wrapped in intact dressings.
    • Hemodynamics: Hypertensive episodes noted; pulse elevated in the high 90s90\text{s} to 100s bpm100\text{s}\,\text{bpm}; oxygen saturation in low 90s%90\text{s}\% on room air (attributed to underlying COPD).
    • Urinary output: Foley drainage bag displaying 350 mL350\,\text{mL} concentrated urine dripping.
    • Electrolyte Profile: Serum Sodium stable; Serum Potassium 3.7 mEq/L3.7\,\text{mEq/L}; Chloride and Bicarbonate within normal limits; BUN 16 mg/dL16\,\text{mg/dL}; Serum Creatinine downtrending at 0.37 mg/dL0.37\,\text{mg/dL} (down from 0.42 mg/dL0.42\,\text{mg/dL} yesterday).
    • Electrolyte Derangements: Serum Calcium 7.7 mg/dL7.7\,\text{mg/dL} (low), Serum Magnesium 1.9 mg/dL1.9\,\text{mg/dL}, Serum Phosphorus 2.6 mg/dL2.6\,\text{mg/dL} (low).
    • Hematology: Hemoglobin at 8.9 g/dL8.9\,\text{g/dL} (9.9 g/dL9.9\,\text{g/dL} yesterday, 8.1 g/dL8.1\,\text{g/dL} two days prior). Mild total protein suppression; no acute leukocytosis.

Infectious Disease, Surgical, and Oncology Management

  • Inpatient Plan for 77-Year-Old Male:

    • Trial of Void: Perform repeat trial of void today using Flomax (tamsulosin); perform bladder scans every 4 hours4\,\text{hours} to monitor post-void retention prior to discharge planning for potential Skilled Nursing Facility (SNF) placement.
    • Glycemic Plan: Maintain Lantus dosing. Following UTI clearance, evaluate re-starting SGLT2 inhibitor prior to discharge; continue holding Metformin during acute illness.
    • Infectious Disease Consultation: ID recommendation for discharge transition to oral Augmentin (amoxicillin/clavulanate) plus Doxycycline 100 mg100\,\text{mg} orally; remain on IV Unasyn/Vancomycin while hospitalized.
  • Vascular & Surgical Evaluation:

    • Physical Exam: Marked blanching, edema, and open-line skin discoloration of the right upper extremity.
    • Vascular Assessment: Right radial artery pulse absent; right ulnar artery pulse present and intact. Intact distal sensation in right hand; range of motion restricted. Surgical incision intact and clean (dressings replaced yesterday).
    • Pain Management: Anesthesia scheduled to perform a targeted nerve block for extremity pain.
    • Medication Hold: Antihypertensive regimen held since 8:00 AM8\text{:00 AM} pending surgical procedure decision.
    • Gastrointestinal Management: Completing Fidaxomicin 200 mg BID200\,\text{mg}\text{ BID} course for Clostridioides difficile infection. Asymptomatic with present bowel sounds and appropriate ostomy bag output.
    • Fluid Management: Systolic blood pressure transiently in the 70s mmHg70\text{s}\,\text{mmHg}; initiated low-rate D5W infusion while NPO.
  • Ms. Barr Management (74-Year-Old Female):

    • Hospital Course: Downgraded to step-down/floor following initial admission for septic shock secondary to UTI and altered mental status.
    • Pathology Findings: Tissue path confirmed diagnosis of colorectal adenocarcinoma.
    • Staging & Workup: Staging CT imaging completed; negative for distant metastasis. Medical Oncology and Colorectal Surgery consulted.
    • Disposition Options: Outpatient staging and surgical workup can be pursued if family declines inpatient surgical intervention.
    • Physical Status: Afebrile; SpO2\text{SpO}_2 at 100%100\% on room air; clear urine output (200 mL200\,\text{mL} in collection bag). Lungs show coarse inspiratory sounds at baseline; left hand swelling decreased.

Acute Diagnostic Workup: Pericarditis, Infectious Mononucleosis, and Splenic Assessment

  • Presentation & Initial Workup (20-Year-Old Female):

    • Presentation: Emergency admission for sudden-onset thoracic chest pain, fever, and persistent tachycardia; admitted for rule-out sepsis.
    • Etiology: Positive Monospot test confirming Infectious Mononucleosis (EBV infection); contact history includes partner diagnosed with pneumonia.
    • Cardiac Diagnostic Impression: Suspected acute pericarditis based on severe pleuritic chest pain and elevated inflammatory markers.
    • Initial Pharmacotherapy: Initiated NSAIDs, Colchicine, and a single empiric dose of Rocephin (ceftriaxone).
  • Symptom Trajectory & Clinical Status:

    • Gastrointestinal Symptoms: Single episode of acute emesis, persistent nausea, and obstipation/constipation (3 days3\,\text{days} without a bowel movement). Administered laxative/bowel regimen and single IV fluid bolus.
    • Chest Pain Characteristics: Continuous burning pleuritic chest pain aggravated by body movement, accompanied by persistent headaches.
    • Hemodynamics: Afebrile overnight; blood pressure stable around 100/60 mmHg100/60\,\text{mmHg}; pulse elevated in 90s90\text{s} to low 100s bpm100\text{s}\,\text{bpm}; elevated respiratory rate; normal SpO2\text{SpO}_2 on room air.
  • Laboratory & Diagnostic Findings:

    • Complete Blood Count: Leukopenia with WBC at 3.1×103/μL3.1 \times 10^3/\mu\text{L}; progressive thrombocytopenia down to 129×103/μL129 \times 10^3/\mu\text{L}.
    • Hepatic Panel: Mild transaminitis with ALT at 132 U/L132\,\text{U/L} and AST at 135 U/L135\,\text{U/L}; Alkaline Phosphatase 110 U/L110\,\text{U/L}; normal bilirubin.
    • Cardiac & Inflammatory Markers: C-Reactive Protein (CRP) mildly elevated at 34 mg/L34\,\text{mg/L}; serial Troponins negative; GC/CT PCR negative.
    • Imaging Studies: Transthoracic Echocardiogram (TTE) demonstrated no acute valvular pathology or pericardial effusion. EKG intact without widespread ST elevations.
    • Splenic Evaluation: Abdominal CT revealed significant splenomegaly (splenic length measured at 14 cm14\,\text{cm}).
  • Diagnostic Assessment & Action Plan:

    • Clinical Impression: Infectious Mononucleosis complicated by secondary acute pericarditis, transaminitis, and splenomegaly (14 cm14\,\text{cm}).
    • Differential Diagnosis for Left Shoulder Pain: Referred pain from splenomegaly/splenic subcapsular irritation (Kehr's sign) versus constipation/diaphragmatic irritation versus evolving splenic rupture.
    • Action Plan: Perform abdominal ultrasound to evaluate splenic parenchyma and exclude subcapsular hematoma or splenic rupture. Continue Colchicine, NSAIDs, aggressive bowel regimen, and fluid hydration.
    • Neurologic Evaluation: Low clinical suspicion for acute meningitis despite headache/emesis; Lumbar Puncture (LP) withheld given confirmed Monospot positivity.

Discharge Planning, Social Work, and Case Management

  • Assisted Living & Ambulatory Status:

    • Patient admitted from an Assisted Living Facility (ALF); currently ambulatory.
  • Unhoused Case Management & Social Factors:

    • Living Situation: Patient living out of a motor vehicle (Chevy Trailblazer) parked on the roadside in Braddock.
    • Nursing & Urology Coordination: Physical address required by home health agencies and case management to establish home nursing care and outpatient urology follow-up.
    • Discharge Logistics: Patient requests discharge during daylight hours to safely return to vehicle location.
    • Firearms Management: Local police department confiscated firearms present in the vehicle; patient's mother arranging storage for 1515 additional firearms in Tampa, Florida.
  • Discharge Tasks & Orders:

    • Exertional Oxygen Assessment: Perform exertional oxygen saturation walk test (O2\text{O}_2 walk test).
    • Documentation: Finalize discharge documentation and orders for patients (Gregory, Gordon).
    • Medication Reconciliation: Sign-off completed (level black/dark clearance status).